FR2410476A1 - Peptidoglycan extracts of bacteria, esp. Bacillus species - for stimulating antitumour immunity - Google Patents

Peptidoglycan extracts of bacteria, esp. Bacillus species - for stimulating antitumour immunity

Info

Publication number
FR2410476A1
FR2410476A1 FR7736196A FR7736196A FR2410476A1 FR 2410476 A1 FR2410476 A1 FR 2410476A1 FR 7736196 A FR7736196 A FR 7736196A FR 7736196 A FR7736196 A FR 7736196A FR 2410476 A1 FR2410476 A1 FR 2410476A1
Authority
FR
France
Prior art keywords
extracts
bacteria
esp
peptidoglycan
stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736196A
Other languages
French (fr)
Other versions
FR2410476B1 (en
Inventor
Charles Nauciel
Anne-Francoise Goguel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR7736196A priority Critical patent/FR2410476B1/en
Publication of FR2410476A1 publication Critical patent/FR2410476A1/en
Application granted granted Critical
Publication of FR2410476B1 publication Critical patent/FR2410476B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Use of peptidoglycans (I) in the form of natural, insoluble extracts of bacteria, esp. of the genus Bacillus, as pharmaceuticals is new. Pref. the bacteria used are B. megaterium (ATCC 14581), B.licheniformis (ATCC 9945) and Corynebacterium poinsettiae (NCPPB 846). Pref. compsns. are aq. suspensions, opt. contg. an antiseptic, formulated for admin. by injection. (I) are useful as a complement to other anticancer treatments to prevent metastatis and relapses. They can be administered at about 1 mg/10 kg 1-2 times per week. Their side effects (if any) are less severe than those of C. parvum extracts.
FR7736196A 1977-11-30 1977-11-30 APPLICATION OF PEPTIDOGLYCANS EXTRACTED FROM BACTERIA, PARTICULARLY BACILLUS AS MEDICAMENTS, ESPECIALLY STIMULATING ANTI-TUMOR IMMUNITY Expired FR2410476B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7736196A FR2410476B1 (en) 1977-11-30 1977-11-30 APPLICATION OF PEPTIDOGLYCANS EXTRACTED FROM BACTERIA, PARTICULARLY BACILLUS AS MEDICAMENTS, ESPECIALLY STIMULATING ANTI-TUMOR IMMUNITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7736196A FR2410476B1 (en) 1977-11-30 1977-11-30 APPLICATION OF PEPTIDOGLYCANS EXTRACTED FROM BACTERIA, PARTICULARLY BACILLUS AS MEDICAMENTS, ESPECIALLY STIMULATING ANTI-TUMOR IMMUNITY

Publications (2)

Publication Number Publication Date
FR2410476A1 true FR2410476A1 (en) 1979-06-29
FR2410476B1 FR2410476B1 (en) 1980-08-22

Family

ID=9198322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736196A Expired FR2410476B1 (en) 1977-11-30 1977-11-30 APPLICATION OF PEPTIDOGLYCANS EXTRACTED FROM BACTERIA, PARTICULARLY BACILLUS AS MEDICAMENTS, ESPECIALLY STIMULATING ANTI-TUMOR IMMUNITY

Country Status (1)

Country Link
FR (1) FR2410476B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024941A2 (en) * 1979-08-30 1981-03-11 Yamanouchi Pharmaceutical Co., Ltd. Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
EP0026746A1 (en) * 1979-10-02 1981-04-08 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FR2502496A2 (en) * 1981-03-30 1982-10-01 Pasteur Institut Aerobic bacterial fractions, esp. Corynebacterium catarrhalis - are medicaments with adjuvant, immunostimulant, antibacterial and interferon-inducing activity

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101148637B (en) * 2007-08-10 2011-05-11 华南理工大学 Hydrolysate enriched with biological bioactive peptide for accelerating beer yeast fermenting and its preparation method and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218888A1 (en) * 1973-02-23 1974-09-20 Wellcome Found

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218888A1 (en) * 1973-02-23 1974-09-20 Wellcome Found

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1971 *
CA1973 *
CA1974 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024941A2 (en) * 1979-08-30 1981-03-11 Yamanouchi Pharmaceutical Co., Ltd. Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
EP0024941A3 (en) * 1979-08-30 1981-12-02 Yamanouchi Pharmaceutical Co. Ltd. Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
EP0026746A1 (en) * 1979-10-02 1981-04-08 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FR2502496A2 (en) * 1981-03-30 1982-10-01 Pasteur Institut Aerobic bacterial fractions, esp. Corynebacterium catarrhalis - are medicaments with adjuvant, immunostimulant, antibacterial and interferon-inducing activity

Also Published As

Publication number Publication date
FR2410476B1 (en) 1980-08-22

Similar Documents

Publication Publication Date Title
AU3636071A (en) Medicament injectors
ES2180251T3 (en) COMPRESSED COVERED WITH POLYMER, CONTAINING AMOXYCLINE AND CLAVULANATE.
PH11870A (en) 14-desoxy-14-(substituted acetoxy)mutilins,their pharmaceutical compositions and method inhibiting bacterial infection
GB1380171A (en) Medicinal tablets
FR2410476A1 (en) Peptidoglycan extracts of bacteria, esp. Bacillus species - for stimulating antitumour immunity
CA976897A (en) Treatment of microorganism cells
CA934270A (en) Vanne de detente d'un fluide sous pression
DE3569673D1 (en) Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
ES402137A1 (en) Antibiotic em{14 49
FR1605222A (en) Vaccine against salmonella choleraesuis infection
GB1294767A (en) Enzyme for lysing cells of dental caries-inducing microorganisms
GB1230455A (en)
ES425945A1 (en) Penicillins
ES377822A1 (en) Dental preparations containing orotic acid
JPS6171B2 (en)
GB1071538A (en) Composition and process
GB1512378A (en) Pharmaceutical formulations
CA957941A (en) Pharmaceutical compositions containing 4,7-phenanthroline 5,6 quinone, pancreatin, bromelin and dehydrocholic acid
FR2154506A1 (en) Medicaments contg biotin - as hypoglycaemic agents
CA851687A (en) Pharmaceutical composition containing 4,7-phenanthrolin-5,6-quinone, pancreatin, bromelin, dehydrocholic acid and 7-iodo-5-chloro-8-hydroxyquinoline
AU465099B2 (en) A process for rearrangement or reduction of 1-derivatives of 1-hydroxybenzimidazoles and 1-hydroxyimidazo (4,5-b) pyridines
ES369356A1 (en) Bacterial culture extracts
CA864531A (en) Enzymic treatment of natural products
AU464542B2 (en) Reduction of microorganism populations of articles
CA876121A (en) Amidines and their use as anthelmintic agents

Legal Events

Date Code Title Description
ST Notification of lapse